Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonsquamous Non-Small Cell Neoplasm of Lung”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Testing effectiveness (Phase 2)Ended earlyNCT02019979
What this trial is testing

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVNon-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Beth Israel Medical Center 14
Large-scale testing (Phase 3)Ended earlyNCT04786964
What this trial is testing

Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC

Who this might be right for
Metastatic Non-squamous Non Small Cell Lung Cancer
Checkpoint Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Ended earlyNCT02119650
What this trial is testing

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation 76
Testing effectiveness (Phase 2)Looking for participantsNCT06426511
What this trial is testing

CtDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Sun Yat-sen University 80
Testing effectiveness (Phase 2)UnknownNCT03830411
What this trial is testing

Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 76
Large-scale testing (Phase 3)Active Not RecruitingNCT06305754
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 550
Testing effectiveness (Phase 2)Study completedNCT00550173
What this trial is testing

Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Eli Lilly and Company 247
Large-scale testing (Phase 3)Study completedNCT02578680
What this trial is testing

Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)

Who this might be right for
Non-Small-Cell Lung Carcinoma
Merck Sharp & Dohme LLC 616
Testing effectiveness (Phase 2)UnknownNCT05812534
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Second Affiliated Hospital of Nanchang University 36
Large-scale testing (Phase 3)UnknownNCT04416035
What this trial is testing

Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC

Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Zhejiang Teruisi Pharmaceutical Inc. 608
Testing effectiveness (Phase 2)Ended earlyNCT04032704
What this trial is testing

Ladiratuzumab Vedotin in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CancerNon-small Cell Lung Cancer, SquamousNon-small Cell Lung Cancer, Non-squamous+6 more
Seagen Inc. 205
Large-scale testing (Phase 3)Study completedNCT00982111
What this trial is testing

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 633
Testing effectiveness (Phase 2)UnknownNCT03654027
What this trial is testing

Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC

Who this might be right for
Non-small Cell Lung Cancer
First Affiliated Hospital of Guangxi Medical University 84
Large-scale testing (Phase 3)Not Yet RecruitingNCT07383116
What this trial is testing

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non Squamous Non-small Cell Lung Cancer
Shanghai Huaota Biopharmaceutical Co., Ltd. 500
Post-approval studies (Phase 4)Study completedNCT01020786
What this trial is testing

A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 109
Testing effectiveness (Phase 2)Ended earlyNCT06173505
What this trial is testing

Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Xencor, Inc. 28
Large-scale testing (Phase 3)UnknownNCT04750083
What this trial is testing

HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Taizhou Hanzhong biomedical co. LTD 700
Testing effectiveness (Phase 2)Study completedNCT01705184
What this trial is testing

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Intergroupe Francophone de Cancerologie Thoracique 120
Not applicableStudy completedNCT01814163
What this trial is testing

Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
Spanish Lung Cancer Group 200
Testing effectiveness (Phase 2)Study completedNCT02259582
What this trial is testing

Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
OncoMed Pharmaceuticals, Inc. 82
Next Page